Abstract:Autophagy may be a major mechanism by which osteoblasts (OBs) protect against the negative effects of chronic glucocorticoid (GC) usage. OBs are closely associated with the remodeling that occurs in GC-induced osteoporosis (GIO). In osteocytes, in response to stress induced by GCs, several pathways are activated, including cell necrosis, apoptosis and autophagy. However, the role of autophagy in OBs following treatment with excess GCs has not been addressed. In the current study, confocal microscopy observation of green fluorescent protein-microtubule-associated protein 1 light chain 3 beta (LC3) punctuate, and western blotting for LC3II and Beclin 1 were performed for detection of autophagy in the MC3T3-E1 osteoblastic cell line. Flow cytometry and western blotting were used for the examination of apoptosis and expression of BAX apoptosis regulator (Bax)/apoptosis regulator Bcl-2 (Bcl-2). The expression of genes associated with osteoblastic function, runt-related transcription factor 2, alpha-1 type 1 collagen and osteocalcin, were measured by reverse transcription-quantitative polymerase chain reaction. The results indicated that autophagy was induced in OBs during dexamethasone (Dex) treatment in a dose-dependent manner. The level of autophagy did not continue to increase over time, but peaked at 48 h and then decreased gradually. Subsequently, flow cytometry was used to demonstrate that inhibition of autophagy induced apoptosis in OBs under Dex treatment, and was associated with the upregulation of Bax and the downregulation of Bcl-2 protein expression. Furthermore, the data suggested that the inhibition of autophagy also suppressed the expression of osteoblastic genes. By contrast, the stimulation of autophagy maintained the gene expression level under Dex treatment. The data revealed that autophagy is an important regulator of osteoblastic apoptosis through its interaction with Bax/Bcl-2, and maintains the osteoblastic function of MC3T3-E1 cells following GC exposure. In addition, these results indicated that the suppression of autophagy in OBs under chronic GC therapy may increase the prevalence of GIO and fragility fractures.

Pro-inflammatory Cytokines: Cellular and Molecular Drug Targets for Glucocorticoid-induced-osteoporosis Via Osteocyte

Pathogenic Mechanisms of Glucocorticoid-Induced Osteoporosis

The Critical Role of T Cells in Glucocorticoid-Induced Osteoporosis

Glucocorticoids and osteocyte autophagy

Recent advances in the glucocorticoid-induced osteoporosis

Glucocorticoid-Induced Autophagy in Osteocytes

Linking the relation between gut microbiota and glucocorticoid-induced osteoporosis

Glucocorticoids and bone: local effects and systemic implications

Glucocorticoid-induced Expansion of Classical Monocytes Contributes to Bone Loss

[The effects of glucocorticoid on expression of cannabinoid-1 receptors in osteoclasts from tibial proximal metaphysis of rats].

Polarization Behavior of Bone Macrophage as Well as Associated Osteoimmunity in Glucocorticoid-Induced Osteonecrosis of the Femoral Head

Glucocorticoid Signaling and Bone Biology

Pro-Inflammatory Cytokines: New Potential Therapeutic Targets for Obesity-Related Bone Disorders.

Glucocorticoid-induced autophagy and apoptosis in bone

Influence of Glucocorticoids on the Osteogenic Differentiation of Rat Bone Marrow-Derived Mesenchymal Stem Cells

Autophagy Relieves the Function Inhibition and Apoptosis‑promoting Effects on Osteoblast Induced by Glucocorticoid.

Mechanism of modified danggui buxue decoction in glucocorticoid-induced osteoporosis: A discussion based on network pharmacology and molecular docking

The osteocytic actions of glucocorticoids on bone mass, mechanical properties, or perilacunar remodeling outcomes are not rescued by PTH(1-34)

Ortho-silicic Acid Plays a Protective Role in Glucocorticoid-Induced Osteoporosis Via the Akt/Bad Signal Pathway in Vitro and in Vivo.

Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis

Glucocorticoid impairs cell-cell communication by autophagy-mediated degradation of connexin 43 in osteocytes